BLOODPAC will be hosting a dinner on the evening of Friday, September 13, 2024, in Barcelona, Spain, during the ESMO Congress 2024. This event aims to foster collaboration with industry leaders to advance the integration of liquid biopsy into mainstream medical conversations and practices across Europe.

The BLOODPAC Global Regulatory and Accessibility Working Groups are currently drafting a comprehensive paper titled "Enhancing Cancer Care in Europe through Advanced Liquid Biopsy Technologies: Challenges and Collaborative Solutions." This paper will outline the obstacles and propose integrated solutions to improve the availability of liquid biopsy for patients. As a follow up to that publication, BLOODPAC would like to catalyze the creation of a United States-European Union project dedicated to overcoming these challenges and developing a roadmap for accelerating patient access to liquid biopsy technologies in Europe.

The primary objective of the dinner is to discuss BLOODPAC's strategic initiatives and explore potential collaborations to address the barriers to liquid biopsy accessibility in Europe, such as regulatory hurdles, market adoption, and patient access. By leveraging the insights and content generated by BLOODPAC, combined with the local expertise of European stakeholders, we aim to create a unified advocacy program to overcome these challenges. Together, we will establish new projects tailored to the European market, accelerating the adoption and integration of liquid biopsy technologies.